A series of simulation models were created to evaluate several vendor proposals submitted for automation of the
INTRODUCTION
Mounting cost pressures in the health care industry are forcing health care providers to seek methods to reduce their costs in an increasingly competitive and regulated environment.
A committee was commissioned to investigate the automation of Mayo Clinic's Central Processing Laboratory. The committee was composed of physicians, engineers, financial analysts, programmers, and administrative personnel. The goals of the team were to seek! solutions that would:
1) Improve the service to the patients and physicians, 2) Lower the cost of processing samples, and
3) Lower the risk of infection to the employee TheCentral Processing Laboratory is a critical part of the clinical support infrastructure. The first criteria is to ensure an automated system would improve the service to the patients and physicians by providing a high quality medical specimen to the analytical laboratories in a timely manner. .
Reduced cost is an ongoing challenge to medical care providers, The appropriate automated solution would reduce the long term costs of providing the pre-analytical functions of analytical tests.
The risk of spreading blood borne infection to the health care worker of concern.
Reducing that risk of exposure was a consideration in evaluating the vendor proposals. Estimates of the cost of treating a single accidental exposure to blood or blood components put the cost into hundreds of dollars in testing, medical care, and lost work time. process times were based on average process times observed through time study of the manual process or The first step in the study was to develop a simulation engineering projections. model of the current labor-intensive environment within In addition, the initial model would serve as a baseline measurement against which to compare the other models. Law and Kelton (1991) point out that building a simulation model of the current system will increase the credibility of the simulation study.
One of the first steps in developing a simulation model is to define the entity, or object, within the simulation program that will be followed during the simulation. The entity will cause changes in the model and collect statistics as it travels through the model. We defined the entity for the simulation as the individual tubes of blood that arrived to the laboratory.
To reduce the complexity of the model, we concerned ourselves with the blood samples and disregarded the processing of other specimens. Each simulation model encompassed the activities that occurred within the Central Processing Laboratory. The activity of drawing the blood sample from the patient, the delivery of the specimen, and the post-processing of the sample in the 7
MODEL INPUT
Because the arrival pattern of blood test samples to the laboratory is heaviest during the morning hours, we modeled these arrivals by using the exponential distribution [Law & Kehon, 1991] . The exponential distribution is commonly used for modeling the interarrival times of customers into a system. Figure 2 shows the variability in the hourly inputs to the laboratory. Schriber [1991] describes a model in which the hourly arrival rate varies during the twenty-four hour period. The model incorporates the changes in the intermival rate at different times of the day. These priorities describe the turnaround time needed for a sample and communicate the urgency of the request. In addition, the priority determines which physical location in the Central Processing Laboratory will receive the sample. The physician ordering the blood test determines how quickly the results are needed, and therefore the priority. The mix of blood sample priorities varies throughout the day. During the early morning hours (12:00 am to 5:00 am), the majority of the incoming samples will be high priority blood samples arriving from the hospitals.
While during the morning hours, the mix of incoming tubes will be weighted heavily towards routine samples as outpatients are being seen at the Clinic, Table 1 gives an example of the incoming percentages by time of day. The processing steps required for each blood sample vary as well. An arriving blood sample will undergo one of the following processes: 1) Sort the sample and send to the analytical laboratories.
2) Sort, centrifuge and send to the laboratory.
3) Sort, centrifuge, aliquot and send to the laboratory. This design also allowed the individual samples to be grouped before transport to the analytical laboratones. 
MODEL OUTPUTS
The primary concern of the automation committee was the throughput time of each sample. The ability to process each sample quickly, send the sample to the analytical laboratories, and return the test results to the ordering physician is of utmost importance for patient care. Customer satisfaction for both the patient and the physician is critical to the success of the operation.
Satisfaction
is defined as returning the results of the sample in a timely and accurate manner. The committee was not concerned with queue lengths per se due to the small size of the samples (test tubes). Space exists in the facility for samples to be held until they can be processed. The overall daily average turnaround time was important.
However, the maximum turnaround time during the busy periods of the morning was even more important. Turnaround times that exceeded ninety minutes for any sample were unacceptable.
MODEL CONSTRAINTS
One of the critical resources in the laboratory is the availability of centrifuges. The centrifuges are used to spin the incoming blood samples to separate the blood serum from the blood cells and fibrin. In the current system, which has twenty-four centrifuges, there is a sufficient number of centrifuges to handle the current volume of incoming tubes. Today each centrifuge can accommodate up twenty-four tubes.
The number of centrifuges specified for each vendor differed. Vendor A recommended two centrifuges. Vendor B provided nine centrifuges and Vendor C designed in four centrifuges.
The problem encountered with fewer and larger centrifuges is outlined in Table 2 . We ran the model under the proposed volume scenarios and produced the following results of turnaround times for those samples that needed to be aliquotted before being sent to the laboratory.
(Statistics were also produced for the remaining processing steps). Results from the simulations indicated that each vendor's equipment could provide a turnaround time roughly equivalent to today's system.
CONCLUSIONS
Results of the simulations were included in the final report of the committee that recommended an automation solution for the Central Processing Laboratory. These results, along with the facility requirements, financial effects analysis, site visit information, and requirements for interfaces with our current laboratory information systems, were among the information included in the final report and presentation made to the Department of Laboratory Medicine. The report concluded that the purchase and instrdlation of automated clinical laboratory equipment should be pursued.
Using the SIMAN@ Simulation Language, we were able to successfully model our current system and the three proposed vendor solutions. Since this was the first simulation model that had been developed over the past few years, we learned from our experience and offer the following advice.
1) Provide vision and resources.
Identify an advocate knowledgeable of simulation and allocate the resources to develop successful model(s).
2) Develop a simulation model soon after learning the language.
Do not delay in developing the first model. The enthusiasm from the class experience will wear off and ideas learned will quickly fade.
3) Develop a core group of at least two to three individuals familiar with simulation and the simulation language.
It is helpful to able to bounce ideas off colleagues who are somewhat familiar with simulation and the language in use at your organization. 4) Confirm the validity of your simulation model against the real system.
Keep the ultimate users involved in ensuring the model is reasonable and accurate.
